MEI Pharma Reports Fiscal Year End 2024 Cash Position
19 Sep 2024 //
BUSINESSWIRE
MEI Pharma Aligned On Voruciclib, ME-344 Strategy
11 Apr 2024 //
BUSINESSWIRE
MEI Update from Study Evaluating Voruciclib with Venetoclax in Patients with AML
26 Mar 2024 //
BUSINESSWIRE
MEI Pharma Announces Update of PI Study Evaluating CDK9 Inhibitor Voruciclib
23 May 2023 //
BUSINESSWIRE